DP
XBI icon

Dearborn Partners’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Dearborn Partners’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,705
Closed -$267K – 276
2024
Q3 		$267K Buy
2,705
+265
+11% +$26K 0.01% 242
2024
Q2 		$226K Buy
+2,440
New +$219K 0.01% 245

Other funds holding XBI

BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Dearborn Partners's XBI Position: Q4 2024 in Review

Dearborn Partners sold out of State Street SPDR S&P Biotech ETF (XBI) in Q4 2024, closing a stake of 2,705 shares — an estimated $267K sold.

Dearborn Partners first reported a position in XBI in Q2 2024 and held it in 2 quarters. The position peaked at $267K in Q3 2024. 738 funds tracked by Wall St. Rank hold XBI as of Q4 2024.

  • Dearborn Partners reported no remaining State Street SPDR S&P Biotech ETF position as of Q4 2024 after selling out during the quarter.
  • Dearborn Partners sold 2,705 State Street SPDR S&P Biotech ETF shares in Q4 2024, an estimated $267K.
  • Dearborn Partners first reported a position in State Street SPDR S&P Biotech ETF in Q2 2024 and held it in 2 quarters.
  • Dearborn Partners's State Street SPDR S&P Biotech ETF position peaked at $267K in Q3 2024.
  • 738 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2024.

Based on Dearborn Partners's 13F filing for Q4 2024, filed 7 Feb 2025.